Abstract:With the assistance of molecular docking and 3D-QSAR models established previously, structurally identical F-18- and I-125- labeled benzyloxybenzene derivatives were designed to achieve the early detection of A beta plaques by PET/SPECT imaging. In competition binding assay, ligands 7a and 12a displayed high binding affinities to A beta(42) aggregates with K-i values of 19.5 nM and 23.9 nM, respectively. Specific plaque labeling was observed on the in vitro autoradiography of brain sections from AD patients and Tg mice. In biodistribution, [I-125]7a, [F-18]7a, [I-125]12a and [F-18]12a all exhibited high initial brain uptakes (>5% ID/g at 2 min). [I-125]7a and [I-125]12a cleared fast from the normal brain regions, while corresponding [F-18]7a and [F-18]12a showed slow washout rates. Dynamic microPET/CT and microSPECT/CT imaging data in normal ICR mice were in accordance with in vivo biodistribution results. In vivo metabolism results indicated that the different clearance profiles between the structurally identical F-18- and I-125- labeled tracers could be attributed to different biochemical characteristics of the radiometabolites. Radioiodinated benzyloxybenzene derivatives exhibited good in vivo biostability in brain. Ex vivo autoradiography further confirmed the strong in vivo A beta labeling ability of [I-125]7a. These new fluorinated and iodinated benzyloxybenzenes can develop into PET/SPECT dual imaging agents targeting A beta plaques.

Synthesis and Biodistribution of 125I-Labelled Benzothiazole Derivatives As Β-Amyloid Imaging Agents

QSAR Study of 125I-Labeled 2-(4-aminophenyl)benzothiazole Derivatives As Imaging Agents for Β-Amyloid in the Brain with Alzheimer’s Disease

Radioiodinated Benzimidazole Derivatives As Single Photon Emission Computed Tomography Probes for Imaging of Β-Amyloid Plaques in Alzheimer's Disease

Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for β-amyloid plaques in Alzheimer’s disease

(99M)tc-Labeled-2-arylbenzoxazole Derivatives As Potential Aβ Imaging Probes for Single-Photon Emission Computed Tomography.

~(11)C labelled benzofuran derivatives as a new agent for β-amyloid imaging

(99M)tc-Labeled Dibenzylideneacetone Derivatives As Potential SPECT Probes for in Vivo Imaging of Β-Amyloid Plaque.

Synthesis and biological evaluation of novel technetium-99m labeled phenylbenzoxazole derivatives as potential imaging probes for β-amyloid plaques in brain.

Synthesis and Radioiodinelabeling of β-Amyloid Plaques Imaging Agent 3'-~(131)I-PIB

Preliminary Characterization and in Vivo Studies of Structurally Identical 18F- and 125I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of Β-Amyloid Plaques

18F-Labeled Benzyldiamine Derivatives As Novel Flexible Probes for Positron Emission Tomography of Cerebral Β-Amyloid Plaques.

Preliminary Characterization and In Vivo Studies of Structurally Identical 18 F- and 125 I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques

2-Arylbenzothiazoles Labeled with [cpre/99mtc(co)3] and Evaluated As Β-Amyloid Imaging Probes.

Novel 18F-Labeled Benzoxazole Derivatives As Potential Positron Emission Tomography Probes for Imaging of Cerebral Β-Amyloid Plaques in Alzheimer’s Disease

Novel Imaging Agents for Β-Amyloid Plaque Based on the N-benzoylindole Core.

Novel ¹⁸F-labeled dibenzylideneacetone derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques.

99Mtc-Labeled 2-Arylbenzothiazoles: Aβ Imaging Probes with Favorable Brain Pharmacokinetics for Single-Photon Emission Computed Tomography.

Synthesis and Evaluation of 125I Labeled Chalcone Derivatives Containing Bithiophene Moiety as Potential Aβ Probes

Novel (E)-5-styryl-2,2′-bithiophene Derivatives As Ligands for Β-Amyloid Plaques

99mTc-labeled benzothiazole and stilbene derivatives as imaging agents for Aβ plaques in cerebral amyloid angiopathy

Synthesis and Evaluation of Novel ¹⁸F Labeled 2-Pyridinylbenzoxazole and 2-Pyridinylbenzothiazole Derivatives As Ligands for Positron Emission Tomography (PET) Imaging of Β-Amyloid Plaques.